AI firm Aiforia and Mayo Clinic have exclusively licensed an AI model to improve prediction of colorectal cancer recurrence. The model analyses digitised tissue samples and combines this with clinical parameters to provide a personalised risk score. It will aid informed treatment decisions, potentially reducing unnecessary chemotherapy and better targeting high-risk patients to improve long-term outcomes. The Aiforia-Mayo Clinic collaboration also underlines a commitment to personalized medicine and continuous innovation.
Dashboards, automation on top of palliative care nurses’ wishlist
Aged care nurses in Australia have voiced their interest in improved and integrated technology solutions to provide streamlined end-of-life care, though they face challenges with
